Inhibition of Monoamine Oxidases by Functionalized Coumarin Derivatives: Biological Activities, QSARs, and 3D-QSARs-Reference-Cited by-同舟云学术

Inhibition of Monoamine Oxidases by Functionalized Coumarin Derivatives: Biological Activities, QSARs, and 3D-QSARs

Published:2000-11-11 Issue:25 Volume:43 Page:4747-4758
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Gnerre Carmela¹,Catto Marco¹,Leonetti Francesco¹,Weber Peter¹,Carrupt Pierre-Alain¹,Altomare Cosimo¹,Carotti Angelo¹,Testa Bernard¹

Affiliation:

1. Institut de Chimie Thérapeutique, Université de Lausanne, BEP, CH-1015 Lausanne, Switzerland, and Dipartimento Farmaco-Chimico, University of Bari, I-70125 Bari, Italy

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm001028o

Reference57 articles.

1. Tissue Distribution of Human Monoamine Oxidase A and B mRNA

2. Levodopa in the treatment of Parkinson's disease: A consensus meeting viewpoint

Cited by 254 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-cytotoxic 3-Acetylcoumarin as an Attractive Target for Human Monoamine Oxidase (HMAO) Enzymes;Anticancer Research;2024-05-31

2. Benzopyrone, a privileged scaffold in drug discovery: An overview of FDA‐approved drugs and clinical candidates;Medicinal Research Reviews;2024-03-26

3. Synthesis, Characterization, and Biological Activities of Novel Schiff Bases Derived from 3-acetyl-4-hydroxy-2h-chromen-2-one and 5-(4-ethoxy/ halo substituted phenyl)-1,3,4-oxadiazol-2-amine;International Journal of Scientific Research in Science and Technology;2024-03-16

4. A second life for MAO inhibitors? From CNS diseases to anticancer therapy;European Journal of Medicinal Chemistry;2024-03

5. Advances in Polybenzocoumarins: Synthesis, Applications and Fluorescent Properties;ChemistrySelect;2024-02-28